Introduction
Administration of prostaglandins (PGs) E-2 and F-2\g=a\will provoke contractions of the human uterus at any stage of pregnancy. The use of these compounds for the induction both of labour at term and of abortion is now widespread and well documented (Bygdeman, 1980) . Recently, it has been found that PGs can effect cervical ripening and this property is being put to good clinical advantage (Bygdeman, 1980) . There is evidence also that prostaglandin synthetase inhibitors (PGSI) can inhibit uterine contractions in pregnant and non-pregnant women (Wiqvist, 1979) . Unfortunately, the therapeutic potential of PGSI, as a treatment for pre-term labour, is drastically reduced by the adverse side effect (now well documented) of closure of the ductus arteriosus in utero, after transplacental passage of the drug, leading to primary pulmonary hypertension of the newborn. The occurrence of this phenomenon is consistent with results from studies using experimental animals, strongly suggesting that PGE maintains the patency of the ductus arteriosus in utero (Coceani, Olley & Bodach, 1976) .
There is, therefore, much evidence that PGs probably play a major part in physiological processes associated with pregnancy and parturition. The present paper describes the trends in prostanoid (prostaglandin-like) concentrations in the maternal, fetal and neonatal circulations as well as in amniotic fluid during pregnancy and the events surrounding delivery of the baby. The potential sources of prostanoids at this time are also considered.
Prostanoids in the maternal circulation Reliable measurements of PGE-2 and PGF-2a in peripheral plasma are difficult to obtain because of the low endogenous concentrations present and the ability of platelets to synthesize PGs. 13,14-Dihydro-15-keto-PGF (PGFM) is a major metabolite of PGF which circulates in 10-30-fold higher concentrations than PGF and is not formed by platelets: hence its measurement in peripheral plasma provides a more reliable monitor of PG production (Samuelsson, 1973) . The measurement of 13,14-dihydro-15-keto-PGE remains technically difficult due to its instability in aqueous media (Mitchell, Sors & Flint, 1977) .
Labour is without effect on circulating levels of PGE and PGF, although PGFM values rise progressively (Table 1 ), suggesting that the lungs (and other organs) can metabolize the increasing quantities of E and F PGs secreted by the uterus during labour as reflected by elevated PGFM levels. Raised levels of PGFM in labour had been noted previously in a smaller study (Green, Bygdeman, Toppozada & Wiqvist, 1974) and little change in Table I . Concentrations of prostaglandins (mean ± s.e.m., n = 5-13) (Keirse, 1979 ) (see ). These findings demonstrate that labour is associated with an overall increase in the rate of prostanoid production and again suggest the introduction of a bias towards the secretion of PGE and PGF.
Measurements in amniotic fluid also provided the first indication that amniotomy rapidly increases PG secretion within the uterus, since concentrations of PGF and PGFM are higher in amniotic fluid collected at amniotomy than in liquor obtained by amniocentesis (Turnbull et (After Keirse, 1979.) circulating levels of PGFM which are significantly raised within 5 min of amniotomy or vaginal examination at term and remain elevated for at least 30 min (Sellers, Hodgson, Mitchell, Anderson & Turnbull, 1980 ) (Text- fig. 4a ). The rapidity of the increase in PG levels and especially their appearance in amniotic fluid led to the suggestion that there is a local control of PG synthesis within the uterus. Consistent with this hypothesis are the facts that amniotomy in women at term does not result in oxytocin secretion ) and that epidural anaesthesia is without effect on the PG response to amniotomy (Mitchell, Bibby, Forsling, Anderson & Turnbull, 1978a) . Hence the mechanism that has been demonstrated in late pregnant sheep (Flint, Forsling, Mitchell & Turnbull, 1975) , whereby oxytocin released in response to vaginal and cervical stimulation causes PG secretion by the uterus, is not operative in women at term.
Potential sources of prostanoids
The origin of the raised levels of PGs in both amniotic fluid and peripheral plasma during labour remains controversial. Decidua, fetal membranes and myometrium have all been suggested as possible sources (see Keirse, 1979 (Table 2) . Chorion, decidua and placenta all produce PGs although only the rate of production of 6-keto-PGF-la by amnion is significantly greater after labour ( (Williams, El-Tahir & Marcinkiewicz, 1979) and perhaps a similar action in women may provide a role for prostacyclin in the mechanism of labour. Certainly the high rates of production of prostanoids by amnion are consistent with the suggestion that the trigger for the onset of human labour may reside in the fetal membranes and be prostaglandin in nature (Liggins, Forster, Grieves & Schwartz, 1977) . . The major PGs produced by the umbilical vessels are PGE and 6-keto-PGF-la (Table 3) . Since PGE contracts and prostacyclin dilates umbilical vessels it is possible that their respective rates of intra-mural production regulate the tone of the vessels and that alterations in the ratio of their production rates may contribute to closure at birth. The concentrations of 6-keto-PGF-la and TXB-2 in umbilical plasma have also been determined. Neither 6-keto-PGF-la nor TXB-2 have a significant arterio-venous difference across the umbilical circulation (Mitchell, 1980 (Mitchell, Lucas, Etches, Brunt & Turnbull, 1978c) (Text-fig. 6 ). Mean concentrations of PGF and PGFM are also lower although their differences are not statistically significant. These findings are consistent with the suggestion that the placenta provides a large proportion of the PGE in the fetal circulation at birth and that removal of this source leads to a rapid decline in PGE levels circulating in the neonate. Siegler, Walker, Crouch, Christenson & Jubiz (1977) also found a fall in plasma PGE levels by 2-3 days of age; they suggested that levels then increased into adult life; but the extremely high levels of PGE measured in adult peripheral plasma in the study raise some doubts about this finding. Quite a different pattern obtains for 6-keto-PGF-la and TXB-2 in the perinatal period. By 6 days after vaginal delivery at term neonates have higher circulating levels of both 6-keto-PGF-la and TXB-2 than at birth (Text-fig. 6 ). Infants born pre-term (before 37 completed weeks of pregnancy) but uncomplicated by major disease, have plasma concentrations of PGE, PGF and PGFM on the 6th day of life similar to those of infants born at term. Delivery before term is not, therefore, associated with obvious differences in capacity for PG synthesis and metabolism in the neonatal period. Prostaglandin concentrations have also been monitored in the plasma of pre-term infants during the first 60 days of life (Mitchell et al, 1978c) . PGE levels decline to those of the adult during this period. Levels of PGF and PGFM also fall markedly but are still approximately 3-fold greater than adult levels even 2 months after birth. The more rapid decline in PGE levels may play an active or facilitatory role in the closure of the ductus arteriosus (Coceani et al, 1976) .
Patent ductus arteriosus (PDA) is a serious neonatal disorder. Infants born with a PDA have been shown (Lucas & Mitchell, 1978a) to have excessively high circulating concentrations of PGE, PGF and PGFM (Text- fig. 7 ), the elevation in PGE levels being particularly impressive. Furthermore, falling plasma concentrations of PGF with rising levels of PGE have been reported shortly before clinical symptoms of PDA appear (Friedman & Demers, 1978; Lucas & Mitchell, 1978b 
